| Revenue growth | 6% YoY in FY26 to ₹88.5cr. |
|---|---|
| Margins | EBITDA margins improved to 37.5%; sustainable around 35-40%. |
| Demand visibility | Strong B2C demand; B2G stability via government contracts. |
| Management confidence | High for FY27/28 after resolving regulatory hurdles. |
Growth
FY26 Revenue grew 6% YoY; EBITDA increased 17% to ₹33.2cr; PAT rose 21%. Margins expanded by 330bps to 37.5%.
Outlook
Guided 25-30% growth for FY27/28; FY27 Capex ₹20-25cr; targets revenue of ₹110-120cr for FY28.
Risks
Regulatory delays (PNDT/AERB) impacted project timelines; long receivable cycles from government B2G contracts.
Earnings Call filed with BSE, BSE: 544482. Summary written with AI assistance from the document.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹75.00
- Market cap
- ₹130.7 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 6.8×Sector 53.1×
- Promoter holding
- 71.92%
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Annual General Meeting
Star Imaging and Path Lab Limited has scheduled its 22nd Annual General Meeting for September 29, 2026. The meeting will be conducted via video conferencing.
Star Imaging and Path Lab Annual Report
Star Imaging and Path Lab Limited has released its Annual Report for FY 2025-26. The 22nd AGM is scheduled for September 29, 2026, via video conferencing.
Star Imaging and Path Lab Board Meeting Outcome
The company announced the outcome of its board meeting, including approval of the draft notice for the 22nd AGM and various audit and appointment matters.
Star Imaging and Path Lab Other Announcement
Star Imaging and Path Lab Ltd submitted its Monitoring Agency Report for the quarter ended June 30, 2026, regarding IPO proceeds utilization. The report confirms nil deviation.
Star Imaging and Path Lab Capacity Expansion
Star Imaging upgraded its Tilak Nagar centre with North India's first 1184-slice CT scanner. This enhances diagnostic capabilities and strengthens the company's healthcare infrastructure.
Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reported steady FY26 growth despite regulatory delays in new centers. Management shifted focus to FY27, banking on a capacity ramp-up and improved government receivables to drive momentum.